Detalles de la búsqueda
1.
SARS-CoV-2 infection and transmission in educational settings: cross-sectional analysis of clusters and outbreaks in England
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20178574
2.
Risk of SARS-CoV-2 reinfections in children: prospective national surveillance, January 2020 to July 2021, England
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21267372
3.
Adolescent vaccination with BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine and effectiveness of the first dose against COVID-19: national test-negative case-control study, England
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21267408
4.
Serological responses and six-month trajectories to COVID-19 Comirnaty and Spikevax booster vaccine, September 2021 to January 2022, London, United Kingdom
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22271126
5.
Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21267562
6.
Serological responses to COVID-19 booster vaccine in England
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21266692
7.
Nucleocapsid antibody positivity as a marker of past SARS-CoV-2 infection in population serosurveillance studies: impact of variant, vaccination, and choice of assay cut-off
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21264964
8.
Characterising long COVID more than 6 months after acute infection in adults; prospective longitudinal cohort study, England
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21253633
9.
Emergence of the Delta Variant and risk of SARS-CoV-2 infection in secondary school students and staff: prospective surveillance in 18 schools, England
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21267583
10.
Higher serological responses and increased vaccine effectiveness demonstrate the value of extended vaccine schedules in combatting COVID-19 in England
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21261140
11.
Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: active prospective surveillance, December 2020 to March 2021, England
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21260496
12.
SARS-CoV-2 IgG detection in human oral fluids
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21260121
13.
Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-362319
14.
High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19; a prospective cohort study in England
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20171413
Resultados
1 -
14
de 14
1
Próxima >
>>